Bio-Rad Laboratories Inc (BIO)
279.31
+5.25
(+1.92%)
USD |
NYSE |
May 02, 16:00
278.90
-0.41
(-0.15%)
Pre-Market: 20:00
Bio-Rad Laboratories Cash from Operations (TTM): 374.94M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 374.94M |
| September 30, 2023 | 373.55M |
| June 30, 2023 | 286.87M |
| March 31, 2023 | 242.07M |
| December 31, 2022 | 194.45M |
| September 30, 2022 | 285.66M |
| June 30, 2022 | 504.99M |
| March 31, 2022 | 606.35M |
| December 31, 2021 | 669.46M |
| September 30, 2021 | 792.98M |
| June 30, 2021 | 698.28M |
| March 31, 2021 | 635.77M |
| December 31, 2020 | 584.97M |
| September 30, 2020 | 450.40M |
| June 30, 2020 | 414.48M |
| March 31, 2020 | 477.76M |
| December 31, 2019 | 457.90M |
| September 30, 2019 | 403.10M |
| June 30, 2019 | 365.63M |
| March 31, 2019 | 288.09M |
| December 31, 2018 | 285.49M |
| September 30, 2018 | 249.85M |
| June 30, 2018 | 216.05M |
| March 31, 2018 | 200.69M |
| December 31, 2017 | 104.14M |
| Date | Value |
|---|---|
| September 30, 2017 | 129.52M |
| June 30, 2017 | 152.66M |
| March 31, 2017 | 167.31M |
| December 31, 2016 | 216.07M |
| September 30, 2016 | 157.27M |
| June 30, 2016 | 187.94M |
| March 31, 2016 | 149.32M |
| December 31, 2015 | 186.21M |
| September 30, 2015 | 190.47M |
| June 30, 2015 | 198.85M |
| March 31, 2015 | 237.19M |
| December 31, 2014 | 273.31M |
| September 30, 2014 | 303.65M |
| June 30, 2014 | 267.82M |
| March 31, 2014 | 210.69M |
| December 31, 2013 | 169.14M |
| September 30, 2013 | 184.82M |
| June 30, 2013 | 201.33M |
| March 31, 2013 | 255.24M |
| December 31, 2012 | 266.48M |
| September 30, 2012 | 261.74M |
| June 30, 2012 | 241.56M |
| March 31, 2012 | 278.21M |
| December 31, 2011 | 262.74M |
| September 30, 2011 | 281.63M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
194.45M
Minimum
Dec 2022
792.98M
Maximum
Sep 2021
464.19M
Average
450.40M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
| Agilent Technologies Inc | 1.961B |
| Bruker Corp | 350.10M |
| Azenta Inc | 70.94M |
| Harvard Bioscience Inc | 14.03M |
| Bionano Genomics Inc | -125.18M |